Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma.

W S Dalton1, P L Bergsagel, W M Kuehl

  • 1Clinical Investigations, H. Lee moffitt Cancer Center, Tampa, FL 33612-9497, USA.

Hematology. American Society of Hematology. Education Program
|November 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.

Cancer treatment reviews·2016
Same author

Integration of Cost-Effectiveness Assessment in the Market Access Scheme of Drugs and Medical Devices In France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Analysis of Cost-Effectiveness Assessments In France By The French National Authority For Health (Has).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Exploring Uncertainty in Economic Evaluation Of Medicines: A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

A Cost-Effectiveness Analysis of Treatment for Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) in France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.

Bone marrow transplantation·2015

Understanding multiple myeloma (MM) biology, including genetic abnormalities and chromosomal translocations, is key to developing targeted therapies. Research explores novel treatments and stem cell transplants to improve outcomes for this incurable plasma cell malignancy.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Multiple myeloma (MM) is an incurable plasma cell malignancy.
  • MM is characterized by bone marrow localization and bone lesions.
  • Current treatments palliate but do not cure the disease.

Purpose of the Study:

  • To explore the molecular pathogenesis of MM.
  • To discuss novel therapeutic approaches targeting genetic abnormalities.
  • To review the role of stem cell transplantation in MM treatment.

Main Methods:

  • Review of molecular pathogenesis, including chromosomal translocations and oncogenes like FGFR3.
  • Analysis of preclinical and clinical studies of novel agents (e.g., PS-341, IMiDs).
  • Discussion of autologous and allogeneic stem cell transplant clinical trials, including conditioning regimens.

Related Experiment Videos

Main Results:

  • Insights into chromosomal translocations and FGFR3 mutations in MM genesis and progression.
  • Evidence for novel agents and targeted therapies in preclinical and clinical settings.
  • Evaluation of conditioning regimens and transplant types in MM treatment.

Conclusions:

  • Understanding MM basic biology is crucial for developing targeted therapies.
  • Novel therapeutic strategies and stem cell transplantation offer promising avenues for MM treatment.
  • Continued research into MM pathogenesis and treatment is essential to find a cure.